The United States authorities have announced their intention to transfer 60 million doses of AstraZeneca to other countries.
This was announced by Andy Slavitt, the White House’s chief coronavirus advisor, tweeting:
“The US will provide 60 million doses of AstraZeneca to other countries when available.”
Earlier, the Joe Biden administration announced the priority of vaccinating American citizens, notes the Hill edition. Recently, however, the situation has improved, and millions of doses of AstraZeneca are stored in special warehouses. Vaccines cannot be used in the United States, as the regulator has not yet given permission for their use.
Jen Psaki, a White House spokeswoman, said Monday that “there is no need to use AstraZeneca in the fight against COVID in the next few months,” as three vaccines are licensed and available in the required quantities in the country.
According to Andy Slavitt, vaccines will be transferred to other countries as they become available. At the same time, the adviser did not specify which states will receive support in the form of impressive batches of the drug from the British-Swedish company.
Jeff Zientes, White House Coronavirus Response Coordinator, notes that 10 million doses are ready, with final testing remaining. Another 50 million is planned to be ready for shipping in May-June.
Previously, a number of countries, the first was Denmark, refused to use AstraZeneca due to the occurrence of thrombosis in some cases. The EMA recommended that it be included in the list of possible side complications.